As we were able to verify the bioactivities of the newly discovered TS compounds 3–5 in several cancer cell lines and non-cancerous cells, we aimed to evaluate their potential to induce EPO production in a cell model that is able to naturally produce EPO and is thus more physiologically accurate than reporter cell lines. Here, EPO is linked to cancer.